NovaBay initiates Phase IIb adenoviral conjunctivitis study
Linkedin

NovaBay initiates Phase IIb adenoviral conjunctivitis study

São Paulo : Brazil | May 18, 2012 at 12:52 AM PDT
Source: Pharmaceutical Industry News
XX XX
Views: Pending
 
The study will evaluate the company's NVC-422, to treat adenoviral conjunctivitis, a highly contagious form of pink eye. This global study is expected to enrol approximately 450 patients with confirmed adenoviral conjunctivitis at investigational sites in India, Brazil, and the US. FULL ARTICLE AT Pharmaceutical Industry News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.